Department of Pathology Microbiology and Immunology Archive — Page 7 of 30

August 31, 2023

Cindy Lowe of Translational Pathology Shared Resource wins award from National Society of Histotechnology

Cindy Lowe, research assistant in the Translational Pathology Shared Resource at VUMC, has won the National Society of Histotechnology’s Jules Elias Excellence in Immunohistochemistry & Molecular Techniques Award.

By Wayne Wood
July 14, 2023

Hogan named to American Society for Clinical Pathology ‘40 Under Forty’ list

Vanderbilt’s Melissa Straub Hogan, MD, has been named to the 2023 American Society for Clinical Pathology 40 Under Forty list.

By Anthony Czelusniak
June 28, 2023

Vanderbilt mourns loss of former ‘godfather of grants’ John Hoover Hash

John Hoover Hash, PhD, who as associate dean for Biomedical Sciences and director of Sponsored Research at Vanderbilt University Medical Center oversaw the computerization of VUMC’s grant recording system in the 1980s, died in Nashville on June 20. He was 94.

By Bill Snyder
June 27, 2023

Rare disorder sheds light on dysbindin function

A case study of a rare disorder uncovers roles for the protein dysbindin in the adaptive immune response and suggests that mutations may underlie some cases of very early onset inflammatory bowel disease.

By Sarah E. Glass
From left, Xiang Ye, PhD, Suba Rajendren, PhD, Antiana Richardson, and John Karijolich, PhD, are studying how the cancer-causing virus KSHV commandeers host gene expression and regulatory machinery.
April 20, 2023

Study details RNA editing in virus-infected cancer cells

Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection.

By Leigh MacMillan
The study team includes, from left, Maribeth Nicholson, MD, MPH, Ben Spiller, PhD, Buddy Creech, MD, MPH, Borden Lacy, PhD, Eric Skaar, PhD, MPH, Isaac Thomsen, MD, MSCI, Ivelin Georgiev, PhD, and Danyvid Olivares-Villagomez, PhD.
March 30, 2023

NIH grant launches C. diff vaccine research initiative

Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV.

By Anthony Czelusniak